Phase Holographic Imaging PHI AB (FRA:L5W) PS Ratio: 1.68 (As of Jul. 19, 2026) — 97% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Phase Holographic Imaging PHI AB PS Ratio?

Phase Holographic Imaging PHI AB FRA:L5W PS Ratio is 1.68 as of Jul. 19, 2026, which is 97% below its 10-year median of 60.04. The stock has 5 warning signs investors should review.

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Phase Holographic Imaging PHI AB's share price is €0.0436. Phase Holographic Imaging PHI AB's Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2025 was €0.03. Hence, Phase Holographic Imaging PHI AB's PS Ratio for today is 1.68.

Good Sign:

Phase Holographic Imaging PHI AB stock PS Ratio (=1.8) is close to 10-year low of 1.76.

The historical rank and industry rank for Phase Holographic Imaging PHI AB's PS Ratio or its related term are showing as below:

FRA:L5W' s PS Ratio Range Over the Past 10 Years
Min: 1.76   Med: 60.04   Max: 180.67
Current: 1.8

During the past 13 years, Phase Holographic Imaging PHI AB's highest PS Ratio was 180.67. The lowest was 1.76. And the median was 60.04.

FRA:L5W's PS Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.86 vs FRA:L5W: 1.80

Phase Holographic Imaging PHI AB's Revenue per Sharefor the three months ended in Oct. 2025 was €0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2025 was €0.03.

Warning Sign:

Phase Holographic Imaging PHI AB revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Phase Holographic Imaging PHI AB was -31.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was -12.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 9.50% per year. During the past 10 years, the average Revenue per Share Growth Rate was 2.00% per year.

During the past 13 years, Phase Holographic Imaging PHI AB's highest 3-Year average Revenue per Share Growth Rate was 23.10% per year. The lowest was -12.80% per year. And the median was -0.20% per year.

Back to Basics: PS Ratio


Phase Holographic Imaging PHI AB  (FRA:L5W) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Phase Holographic Imaging PHI AB PS Ratio Related Terms


Phase Holographic Imaging PHI AB PS Ratio Historical Data

* Premium members only.

The historical data trend for Phase Holographic Imaging PHI AB's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phase Holographic Imaging PHI AB PS Ratio Chart

Phase Holographic Imaging PHI AB Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 98.02 9.88 10.47 18.40 3.72

Phase Holographic Imaging PHI AB Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.44 2.92 3.72 2.89 3.35

FRA:L5W vs ABT, BSX, SYK: PS Ratio Comparison

For the Medical Devices subindustry, Phase Holographic Imaging PHI AB's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Phase Holographic Imaging PHI AB PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Phase Holographic Imaging PHI AB's PS Ratio distribution charts can be found below:

* The bar in red indicates where Phase Holographic Imaging PHI AB's PS Ratio falls into.



Phase Holographic Imaging PHI AB PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Phase Holographic Imaging PHI AB's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.0436/0.026
=1.68

Phase Holographic Imaging PHI AB's Share Price of today is €0.0436.
Phase Holographic Imaging PHI AB's Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.

Frequently Asked Questions Learn more about PS Ratio →
What does a PS Ratio of 1.68 mean?
Phase Holographic Imaging PHI AB (FRA:L5W) has a PS Ratio of 1.68 as of Jul. 19, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Phase Holographic Imaging PHI AB and its competitors. This is 97% below median its historical median of 60.04. Over the past decade, Phase Holographic Imaging PHI AB's PS Ratio has ranged from 1.76 to 180.67.
Is Phase Holographic Imaging PHI AB's PS Ratio too high?
Phase Holographic Imaging PHI AB's current PS Ratio of 1.68 is 97% below median its 10-year median of 60.04. Over the past 10 years, this metric has ranged from a low of 1.76 to a high of 180.67. The Medical Devices & Instruments industry median PS Ratio is 2.86. Phase Holographic Imaging PHI AB's value of 1.68 is 41.3% below this industry median.
How does Phase Holographic Imaging PHI AB's PS Ratio compare to ABT and BSX?
Phase Holographic Imaging PHI AB's PS Ratio of 1.68 can be compared against companies in the Medical Devices & Instruments industry. The industry median PS Ratio is 2.86. Phase Holographic Imaging PHI AB's value of 1.68 is 41.3% below this benchmark. Historically, Phase Holographic Imaging PHI AB's own PS Ratio has ranged from 1.76 to 180.67 over the past decade. While the company's 10-year median is 60.04 vs. the industry median of 2.86, Phase Holographic Imaging PHI AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.86, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Phase Holographic Imaging PHI AB's current PS Ratio of 1.68 is 41.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Phase Holographic Imaging PHI AB and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phase Holographic Imaging PHI AB's current PS Ratio is 1.68, which is 97% below median its own 10-year median of 60.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phase Holographic Imaging PHI AB stock overvalued right now?
Phase Holographic Imaging PHI AB (FRA:L5W) has a current PS Ratio of 1.68. The stock's GF Value™ is €0.23, compared to a current price of €0.04 — trading 81% below its estimated fair value. The current PS Ratio is 1.68, which is 97% below median its 10-year median of 60.04 and 41.3% below the Medical Devices & Instruments industry median of 2.86. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Phase Holographic Imaging PHI AB (FRA:L5W), the current PS Ratio is 1.68 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Phase Holographic Imaging PHI AB Business Description

Address Skiffervagen 48, Lund, SWE, 224 78
Phase Holographic Imaging PHI AB is a medical device company that develops and markets non-invasive time-lapse imaging instruments used for the quantitative long-term analysis of living cell cultures. The company's commercial HoloMonitor products are based on Quantitative Phase Imaging (QPI) technology, which is used for real-time cell quality evaluation. Geographically, it has presence in Lund, Sweden, with offices in Boston, MA and Winston-Salem, NC.